Genetic Susceptibility to Head and Neck Cancer: Interaction Between Nutrition and Mutagen Sensitivity

Laryngoscope - Tập 107 Số 6 - Trang 765-781 - 1997
Stimson P. Schantz1, Zuo‐Feng Zhang2, Margaret S. Spitz3, Ming Sun4, Tao Hsu5
1Stimson P. Schantz, MD, Memorial Sloan‐Kettering Cancer Center, 1275 York Avenue New York, NY 10021, U.S.A.
2Epidemiology and Biostatistics Service, Memorial Sloan‐Kettering Cancer Center, New York, New York
3Department of Epidemiology, M.D. Anderson Cancer Center, Houston, Texas.
4Head and Neck Surgery Service, Memorial Sloan-Kettering Cancer Center, New York, New York
5Department of Cell Biology, M.D. Anderson Cancer Center, Houston, Texas.

Tóm tắt

AbstractThe development of head and neck cancer may depend not only on exposure to environmental carcinogens but also on a genetically based susceptibility to carcinogen‐induced damage. This thesis presents a case‐control study that demonstrates the significance of mutagen sensitivity, a measure of an individual's intrinsic DNA repair capacity against free radical damage, as a risk factor for the disease. As part of the case‐control analysis, 167 previously untreated patients and 177 age‐ and sex‐matched healthy controls were assessed for various lifestyle factors including tobacco and alcohol habits, occupational exposures, and diet. Mutagen sensitivity expressed by each individual was determined by quantifying bleomycin‐induced chromosomal breaks within peripheral blood lymphocytes in vitro. Consistent with our initial observations and those of others, mutagen hypersensitivity was strongly associated with increased risk of head and neck cancer (odds ratio, 4.95; 95% confidence interval, 2.67 to 9.17) after adjusting for age, sex, and race. Low intake of vitamins C and E was also associated with an increased risk of disease and was interactive with mutagen sensitivity in risk estimates. Individuals with both a low intake of various antioxidants and increased chromosomal sensitivity to oxidant‐induced DNA damage were at greatest risk. This study supports the concept that the risk of head and neck cancer is determined by a balance of factors that either enhance or protect against free radical oxygen damage, including innate capacities for DNA repair.

Từ khóa


Tài liệu tham khảo

10.1007/978-1-4615-3468-6_1

Wynder EL, 1977, Comparative epidemiology of to‐bacco‐related cancers, Cancer Res, 37, 4608

10.1002/ijc.2910360510

Winn DM, 1995, Diet and nutrition in the etiology of cancer, Am J Clin Nutr, 61, 437S, 10.1093/ajcn/61.2.437S

10.1016/S0065-230X(08)60266-3

10.1111/j.1601-5223.1983.tb00574.x

10.1016/0165-4608(85)90114-1

Iqbal ZM, 1976, Single‐strand scission and repair of DNA in mammalian cells by bleomycin, Cancer Res, 36, 3834

Sikic BI, 1986, Biochemical and cellular determinants of bleomycin cytotoxicity, Cancer Surv, 5, 82

10.1016/0165-1110(78)90019-2

Wang RY, 1995, DNA fragility and repair capability are separate genetic phenotypes: studies on in tu nick translation and chromosome breakage, Int J Oncol, 6, 51

10.1007/BF00335418

10.1002/hed.2880110409

10.1007/BF02621067

10.1002/ijc.2910430310

Spitz MR, 1989, Chromosome sensitivity to bleomycin‐induced mutagenesis in patients with upper aerodigestive cancers: a case‐control analysis, Cancer Res, 49, 4626

Spitz MR, 1993, Mutagen sensitivity in upper aerodigestive tract cancer, Cancer Epidemiol Biomarkers Prev, 2, 329

Schantz SP, 1989, Young adults with head and neck cancer express increased susceptibility to mutagen‐induced chromosomal damage, JAMA, 262, 3313, 10.1001/jama.1989.03430230098033

10.1002/ijc.2910560610

Li AT, 1994, Pingyangomycin‐induced chromosome damage in lymphocytes of laryngeal cancer patients and healthy control subjects, Head Neck, 16, 510

10.1093/jnci/82.22.1773

10.1093/jnci/86.22.1681

10.1016/0002-9610(91)90134-Y

Trizna Z, 1993, In vitro protective effects of chemopreventive agents against bleomycin‐induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients, Cancer Detect Prevent, 17, 575

Spitz MR, 1988, The development of a comprehensive institutional‐based patient risk evaluation program. Part I. Development, content, and data management, Am J Prev Med, 4, 183, 10.1016/S0749-3797(18)31171-1

Block G, 1985, Nutritional source in the American diet: quantitative data from the NHANES II Survey. Part I. Vitamins and minerals, Am J Epidemiol, 122, 13, 10.1093/oxfordjournals.aje.a114072

Block G, 1985, Nutrient sources in the American diet: quantitative data from the NHANES II Survey. Part II. Macronutrients and fats, Am J Epidemiol, 122, 27, 10.1093/oxfordjournals.aje.a114084

Block G, 1987, A review of validations of dietary assessment methods, Am J Epidemiol, 126, 796

1976, National Health and Nutrition Examination Survey II (NHANES II)

1982, Model gram and nutrient composition

US Department of Agriculture.Nutrient database for standard reference: expansion of data published in Composition of Foods‐Raw Processed Prepared. Revisions of Agriculture Handbook No. 8. Hyattsville MD: US Department of Agriculture May 1988 (computer tape).

Breslow NE, 1980, Statistical Methods in Cancer Research. Vol 1. The Analysis of Case‐Control Studies

Mantel N, 1959, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, 22, 719

10.1093/oxfordjournals.aje.a121626

10.1016/0021-9681(80)90008-9

Schlesselman JJ, 1982, Case‐Control Studies: Design, Conduct, Analysis, 63

10.1146/annurev.nu.13.070193.003021

10.1016/0921-8734(89)90001-5

10.1006/abbi.1993.1074

Halliwell B, 1992, Free radicals, antioxidants, and human disease: where are we now?, J Lab Clin Med, 119, 598

10.1016/0921-8734(90)90001-8

10.1111/j.1749-6632.1993.tb39148.x

10.1016/S0065-230X(08)60824-6

Hoffmann D, 1989, Handbook of Experimental Pharmacology

10.1038/314462a0

10.1111/j.1399-0004.1993.tb04455.x

Dorr RT, 1992, Bleomycin pharmacology: mechanism of action and resistance and clinical pharmacokinetics, Semin Oncol, 19, 3

10.1007/BF00199219

10.1016/0165-1110(91)90022-N

10.1016/0002-9343(94)90292-5

10.3181/00379727-200-43429

10.1016/0165-1218(89)90163-8

Hsu TC, 1991, Ethyl alcohol as a carcinogen with special reference to the aerodigestive tract: a cytogenetic study, Anticancer Res, 11, 1097

Hsu TC, 1991, The role of ethanol in oncogenesis of the upper aerodigestive tract: inhibition of DNA repair, Anticancer Res, 11, 1995

Kumano A, 1987, Synergistic effect of aphidocolin and ethanol on the induction of common fragile sites, Hum Genet, 75, 75, 10.1007/BF00273845

10.1016/0165-1161(89)90009-5

Hsu TC, 1986, Differential susceptibility to a mutagen among human individuals: synergistic effect on chromosome damage between bleomycin and aphidicolin, Anticancer Res, 6, 1171